Profil bibliographique

Jean L. Chan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

110Publications signalées

8943Citations signalées

2Affiliations récentes

Institutions déclarées

Emory University Neurocrine Biosciences (United States)

Domaines associés

Regulation of Appetite and ObesitySexual Differentiation and DisordersAdrenal Hormones and DisordersAdipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment

Publications récentes

Accès ouvert 2025 articleOpenAlex

SUN-441 Crinecerfont Shows Favorable Trends in Improving Clinical Outcomes in Children and Adolescents With Classic Congenital Adrenal Hyperplasia: 1-Year Results From the CAHtalyst™ Pediatric Study

Kyriakie Sarafoglou, Oksana Lekarev, Karen J. Loechner, Ming Yang et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

SUN-440 Evaluation of Potential Drug-Drug Interactions with Crinecerfont

Richard J. Auchus, Kyriakie Sarafoglou, Mitchell E. Geffner, Rosario Pivonello et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

OR07-05 Crinecerfont Maintains Reductions in Serum Androstenedione Levels and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: 1-Year Results from the CAHtalystTM Pediatric Study

Ron S. Newfield, Mitchell E. Geffner, YeouChing Hsu, Mehul Dattani et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

OR07-04 Crinecerfont Allows for More Physiologic Glucocorticoid Treatment With Reduction of Androstenedione to a Normal Range in Adults With Classic Congenital Adrenal Hyperplasia: Post Hoc Analyses of the CAHtalyst™ Adult Study

Oksana Hamidi, Syed Ali Imran, Andrea M. Isidori, Henrik Falhammar et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

SUN-434 Crinecerfont Reduces Plasma Adrenocorticotropic Hormone and Serum 17-Hydroxyprogesterone Levels in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: 1-Year Results from the CAHtalystTM Pediatric Study

Mitchell E. Geffner, Ron S. Newfield, YeouChing Hsu, Mehul Dattani et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

SUN-405 Crinecerfont Shows Favorable Trends in Improving Weight-Related Outcomes in Adults With Classic Congenital Adrenal Hyperplasia: 1-Year Results From the CAHtalyst™ Adult Study

Irina Bancos, Henrik Falhammar, Rosario Pivonello, Gianni Russo et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

MON-459 Crinecerfont Shows Favorable Trends in Improving Weight-Related Outcomes in Pediatric Patients With Classic Congenital Adrenal Hyperplasia: 1-Year Results from the CAHtalyst™ Pediatric Study

Natalie Nokoff, Maria G. Vogiatzi, Mehul Dattani, George Jeha et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

MON-458 Crinecerfont Allows for More Physiologic Glucocorticoid Dosing Regimens in Patients With Classic Congenital Adrenal Hyperplasia: Results from the Phase 3 CAHtalyst™ Adult and CAHtalystTM Pediatric Studies

Natalie Nokoff, Kanthi Bangalore Krishna, Leen Antonio, Robert Farber et autres

0 citationsJournal of the Endocrine Society

Accès ouvert 2025 articleOpenAlex

Early versus Late Postoperative Renal Replacement Therapy and Associated Outcomes Following Combined Heart-Kidney Transplantation: A UNOS National Database Analysis

Cong He, H. Abadiotakis, S. S. Randhawa, C.J. Rust et autres

0 citationsAmerican Journal of Transplantation

Accès ouvert 2025 articleOpenAlex

Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicines

Spencer C. Wei, Aaron J. Cantor, Jack Walleshauser, Rina J. Mepani et autres

1 citationPLoS ONE

2025 conference-abstractOpenAlex

Crinecerfont improves reproductive hormones in classic congenital adrenal hyperplasia: 1-year results from the phase 3 CAHtalyst adult study

Deborah P. Merke, Sonal Vaid, Maamoun Salam, Duarte Pignatelli et autres

0 citationsEndocrine Abstracts

2025 conference-abstractOpenAlex

Crinecerfont enables glucocorticoid dose reductions while maintaining/improving androstenedione in paediatric patients with congenital adrenal hyperplasia: subgroup analyses from CAHtalyst paediatric

Oksana Lekarev, Ayca Erkin‐Cakmak, Maria G. Vogiatzi, Erik A. Imel et autres

0 citationsEndocrine Abstracts

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.